Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Executive Board Appointments

13 Aug 2021 07:00

RNS Number : 5737I
Supply @ME Capital PLC
13 August 2021
 

13 August 2021

Supply@ME Capital plc

(The "Company" or "SYME")

 

Thomas James and John Collis appointed as SYME Executive Directors

 

Following the recent successful completion of the acquisition of TradeFlow Capital Management Pte Ltd. ("TradeFlow"), and the Company's 2020 Annual General Meeting held on 30 July 2021, Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation© service to manufacturing and trading companies, is pleased to confirm the appointments of Dr Thomas James and Mr John Collis to the Board of the Company as Executive Directors.

 

Dr James and Mr Collis will continue in their current executive roles, leading the TradeFlow business.

 

The following information is disclosed pursuant to the QCA Corporate Governance Code and best practice:

 

Thomas Glyn James (Tom James) (aged 49) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Skybird Records Ltd.

Navitas Resources Capital Ltd

Commodity Partners International Ltd.

TradeFlow Capital Management Systems Pte Ltd

Tijara Pte Ltd

Navitas Resources (UK) Ltd. (Dormant)

Navitas Resources Pte Ltd. (Dormant)

 

Dr. James currently holds 406,500,000 Ordinary shares in the Company.

 

John Charles Collis (aged 51) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

TradeFlow Capital Management Pte Ltd.

NR Capital Pte Ltd.

Kenwood Secretaries Ltd

International Knowledge Ltd

TradeFlow Capital Management Systems Pte Ltd

Navitas Resources Capital Ltd

Tijara Pte Ltd

Kenwood Nominees Ltd

JCS 110 Ltd

Higher Education Research Ltd

English Pocket Opera Company

MTI Solutions Ltd

JCS 105 Ltd

Ultraponix Ltd

Price Verifier System Ltd

SoftNPower Ltd

JCS 107 Ltd

 

 

 

Mr Collis currently holds 406,500,000 Ordinary shares in the Company.

 

There is no further information on either Director to be disclosed pursuant to The LSE Standard Listing Rulebook.

 

Notes

Supply@ME enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which the business intends to sell to the end-customers or goods/ commodities part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables strong companies to improve their working capital cycle. The funds do not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGUGDILXBDGBX
Date   Source Headline
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.